Olema Pharmaceuticals, Inc. Common Stock (OLMA) is a publicly traded Healthcare sector company. As of May 21, 2026, OLMA trades at $13.90 with a market cap of $1.13B and a P/E ratio of -7.24. OLMA moved +6.72% today. Year to date, OLMA is -44.38%; over the trailing twelve months it is +174.80%. Its 52-week range spans $2.86 to $36.26. Analyst consensus is strong buy with an average price target of $39.75. Rallies surfaces OLMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OLMA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OLMA recently traded at $13.90. Market cap is $1.13B. P/E ratio is -7.24. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $13.90 |
| Market Cap | $1.13B |
| P/E Ratio | -7.24 |
| EPS | $-1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.26 |
| 52-Week Low | $2.86 |
| Volume | 17.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-162.45M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-162.45M | $-1.87 |
| 2024 | $0 | $-129.47M | $-2.20 |
| 2023 | $0 | $-96.66M | $-2.14 |
| 2022 | $0 | $-104.79M | $-2.62 |
11 analysts cover OLMA: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.75.